Mark John Austin - Net Worth and Insider Trading

Mark John Austin Net Worth

The estimated net worth of Mark John Austin is at least $81,585 dollars as of 2024-05-24. Mark John Austin is the VP Finance/Prin Fin&Acct Offic of Perspective Therapeutics Inc and owns about 54,030 shares of Perspective Therapeutics Inc (CATX) stock worth over $81,585. Details can be seen in Mark John Austin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark John Austin has not made any transactions after 2022-06-09 and currently still holds the listed stock(s).

Transaction Summary of Mark John Austin

To

Mark John Austin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark John Austin owns 1 companies in total, including Perspective Therapeutics Inc (CATX) .

Click here to see the complete history of Mark John Austin’s form 4 insider trades.

Insider Ownership Summary of Mark John Austin

Ticker Comapny Transaction Date Type of Owner
CATX Perspective Therapeutics Inc 2022-06-09 Controller/Prin Fin&Acct Offic

Mark John Austin Latest Holdings Summary

Mark John Austin currently owns a total of 1 stock. Mark John Austin owns 54,030 shares of Perspective Therapeutics Inc (CATX) as of June 9, 2022, with a value of $81,585.

Latest Holdings of Mark John Austin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CATX Perspective Therapeutics Inc 2022-06-09 54,030 1.51 81,585

Holding Weightings of Mark John Austin


Mark John Austin Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark John Austin has made a total of 2 transactions in Perspective Therapeutics Inc (CATX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Perspective Therapeutics Inc is the acquisition of 18,800 shares on June 9, 2022, which cost Mark John Austin around $5,452.

Insider Trading History of Mark John Austin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark John Austin Trading Performance

GuruFocus tracks the stock performance after each of Mark John Austin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark John Austin is 125.22%. GuruFocus also compares Mark John Austin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark John Austin within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark John Austin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark John Austin

Average Return

Average return per transaction

Outperforming Transactions

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.23
Relative Return to S&P 500(%) 1.11

Mark John Austin Ownership Network

Ownership Network List of Mark John Austin

No Data

Ownership Network Relation of Mark John Austin


Mark John Austin Owned Company Details

What does Perspective Therapeutics Inc do?

Who are the key executives at Perspective Therapeutics Inc?

Mark John Austin is the Controller/Prin Fin&Acct Offic of Perspective Therapeutics Inc. Other key executives at Perspective Therapeutics Inc include Chief Medical Officer Markus Puhlmann , Chief Financial Officer Jonathan Robert Hunt , and Vice President Lori A Woods .

Perspective Therapeutics Inc (CATX) Insider Trades Summary

Over the past 18 months, Mark John Austin made no insider transaction in Perspective Therapeutics Inc (CATX). Other recent insider transactions involving Perspective Therapeutics Inc (CATX) include a net purchase of 342,424 shares made by Williamson Robert F Iii , a net purchase of 875,425 shares made by Markus Puhlmann , and a net purchase of 210,404 shares made by Jonathan Robert Hunt .

In summary, during the past 3 months, insiders sold 0 shares of Perspective Therapeutics Inc (CATX) in total and bought 60,431,039 shares, with a net purchase of 60,431,039 shares. During the past 18 months, 0 shares of Perspective Therapeutics Inc (CATX) were sold and 62,044,492 shares were bought by its insiders, resulting in a net purchase of 62,044,492 shares.

Perspective Therapeutics Inc (CATX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Perspective Therapeutics Inc Insider Transactions

No Available Data

Mark John Austin Mailing Address

Above is the net worth, insider trading, and ownership report for Mark John Austin. You might contact Mark John Austin via mailing address: 350 Hills St, Ste 106, Richland Wa 99354.

Discussions on Mark John Austin

No discussions yet.